OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference
OPKO Health, Inc. (Nasdaq: OPK) will participate in the 41st Annual J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health, Inc. (Nasdaq: OPK) will participate in the 41st Annual J.P. Morgan Healthcare Conference from January 9-12, 2023, in San Francisco. The management will conduct one-on-one meetings and present on January 11 at 4:30 p.m. Pacific time. The presentation will be available via live webcast and later for replay on the OPKO Health website. As a multinational biopharmaceutical and diagnostics company, OPKO aims to lead in rapidly growing markets through innovative technologies and development capabilities.
Details
News Market Reaction – OPK
The recorded move for OPK in the trading session of this news was -2.40%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, Jan. 03, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the 41st Annual J.P. Morgan Healthcare Conference being held January 9-12, 2023 at the Westin St. Francis in San Francisco. Management will be hosting one-on-one meetings with investors and will be presenting on Wednesday, January 11th at 4:30 p.m. Pacific time.
The presentation will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
LHA Investor Relations
Yvonne Briggs, 310-691-7100
ybriggs@lhai.com
or
Bruce Voss, 310-691-7100
bvoss@lhai.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.